Human bocaviruses and paediatric infections.


Journal

The Lancet. Child & adolescent health
ISSN: 2352-4650
Titre abrégé: Lancet Child Adolesc Health
Pays: England
ID NLM: 101712925

Informations de publication

Date de publication:
06 2019
Historique:
received: 21 12 2018
revised: 14 02 2019
accepted: 15 02 2019
pubmed: 6 4 2019
medline: 20 5 2020
entrez: 6 4 2019
Statut: ppublish

Résumé

Human bocavirus 1 (HBoV1), belonging to the Parvoviridae family, was discovered in 2005, in nasopharyngeal samples from children with respiratory tract infections. Three additional bocaviruses, HBoV2-4, were discovered in 2009-10. These viruses have mainly been found in faecal samples and their role in human diseases is still uncertain. HBoV1 causes a wide spectrum of respiratory diseases in children, including common cold, acute otitis media, pneumonia, bronchiolitis, and asthma exacerbations. HBoV1 DNA can persist in airway secretions for months after an acute infection. Consequently, acute HBoV1 infection cannot be diagnosed with standard DNA PCR; quantitative PCR and serology are better diagnostic approaches. Because of their high clinical specificity, diagnostic developments such as HBoV1 mRNA and antigen detection have shown promising results. This Review summarises the knowledge on human bocaviruses, with a special focus on HBoV1.

Identifiants

pubmed: 30948251
pii: S2352-4642(19)30057-4
doi: 10.1016/S2352-4642(19)30057-4
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

418-426

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Andreas Christensen (A)

Department of Medical Microbiology, St Olavs Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Electronic address: andreas.christensen@stolav.no.

Olli Kesti (O)

Department of Paediatrics, Turku University Hospital and University of Turku, Turku, Finland.

Varpu Elenius (V)

Department of Paediatrics, Turku University Hospital and University of Turku, Turku, Finland.

Anna L Eskola (AL)

Department of Education, University of Turku, Turku, Finland.

Henrik Døllner (H)

Department of Pediatrics, St Olavs Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Can Altunbulakli (C)

Swiss Institute of Allergy and Asthma Research, University of Zürich and Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.

Cezmi A Akdis (CA)

Swiss Institute of Allergy and Asthma Research, University of Zürich and Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.

Maria Söderlund-Venermo (M)

Department of Virology, University of Helsinki, Helsinki, Finland.

Tuomas Jartti (T)

Department of Paediatrics, Turku University Hospital and University of Turku, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH